Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The astringent effect in the gastrointestinal (GI) tract refers to the physiological and sensory responses triggered by astringent substances, primarily polyphenols, when they interact with tissues and receptors within the gut. This interaction involves protein binding, activation of TRP channels, and modulation of gastrointestinal hormones, leading to diverse physiological outcomes, including mucosal protection, altered protein digestion, and potential metabolic benefits.
Astringency in the GI tract is a complex physiological response involving polyphenol-protein interactions, activation of somatosensory pathways (TRP channels), and modulation of gastrointestinal hormones. It leads to altered protein digestibility, mucosal protection, and potential benefits for gut microbiota and overall metabolic health.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal Tract (Astringent Effect) (GI Tract (Astringency)).